loading...| Preferred Name | lanreotide | |
| Synonyms |
Nal-cyclo(Cys-Tyr-Trp-Lys-Val-Cys)Thr-NH2 3-(2-naphthyl)-D-Ala-Cys-Tyr-D-Trp-Lys-Val-Cys-Thr-NH2 BIM 23014 C Somatulin Somatuline DC-13-116 lanreotide acetate 188Re-lanreotide 2-naphthylalanyl-cyclo(cysteinyl-tyrosyl-tryptophyl-lysyl-valyl-cysteinyl)-threoninamide BIM-23014 Somatulina BIM 23014 BIM 23014C naphthalenyl-cyclo(cysteinyl-tyrosyl-tryptophyl-lysyl-valyl-cysteinyl)threoninamide DC 13-116 DC13-116 D-Nal-Cys-Tyr-Trp-Lys-Val-Cys-Thr-NH2 lanreotide-SR Nal-cyclo(Cys-Tyr-Trp-Lys-Val-Cys)-Thr-NH2 angiopeptin L-Threoninamide, 3-(2-naphthalenyl)-D-alanyl-L-cysteinyl-L-tyrosyl-D-tryptophyl-L-lysyl-L-valyl-L-cysteinyl-, cyclic (2-7)-disulfide naphthyl-cyclo(Cys-Tyr-Trp-Lys-Val-Cys)Thr-NH2 L-Threoninamide, 3-(1-naphthalenyl)-D-alanyl-L-cysteinyl-L-tyrosyl-D-tryptophyl-L-lysyl-L-valyl-L-cysteinyl-, cyclic (2-7)-disulfide BIM-23014 C 3-(2-naphthyl)alanyl-cystinyl-tyrosyl-tryptophyl-lysyl-valyl-cystinyl-threonine amide |
|
| ID |
http://purl.bioontology.org/ontology/MESH/C060347 |
|
| altLabel |
Nal-cyclo(Cys-Tyr-Trp-Lys-Val-Cys)Thr-NH2 3-(2-naphthyl)-D-Ala-Cys-Tyr-D-Trp-Lys-Val-Cys-Thr-NH2 BIM 23014 C Somatulin Somatuline DC-13-116 lanreotide acetate 188Re-lanreotide 2-naphthylalanyl-cyclo(cysteinyl-tyrosyl-tryptophyl-lysyl-valyl-cysteinyl)-threoninamide BIM-23014 Somatulina BIM 23014 BIM 23014C naphthalenyl-cyclo(cysteinyl-tyrosyl-tryptophyl-lysyl-valyl-cysteinyl)threoninamide DC 13-116 DC13-116 D-Nal-Cys-Tyr-Trp-Lys-Val-Cys-Thr-NH2 lanreotide-SR Nal-cyclo(Cys-Tyr-Trp-Lys-Val-Cys)-Thr-NH2 angiopeptin L-Threoninamide, 3-(2-naphthalenyl)-D-alanyl-L-cysteinyl-L-tyrosyl-D-tryptophyl-L-lysyl-L-valyl-L-cysteinyl-, cyclic (2-7)-disulfide naphthyl-cyclo(Cys-Tyr-Trp-Lys-Val-Cys)Thr-NH2 L-Threoninamide, 3-(1-naphthalenyl)-D-alanyl-L-cysteinyl-L-tyrosyl-D-tryptophyl-L-lysyl-L-valyl-L-cysteinyl-, cyclic (2-7)-disulfide BIM-23014 C 3-(2-naphthyl)alanyl-cystinyl-tyrosyl-tryptophyl-lysyl-valyl-cystinyl-threonine amide |
|
| cui |
C1310656 C0106328 C0209211 C1721174 C2713390 C0245665 C0053604 C0245668 C0245769 C0051846 C0771414 |
|
| Has mapping qualifier | ||
| HM |
D010456 D013004/Q000031 |
|
| Inverse of RB |
IEU56G3J9C 0G3DE8943Y 0 |
|
| isa | ||
| LT |
TRD |
|
| Mapped to | ||
| MDA |
19890818 |
|
| MeSH Frequency |
850 |
|
| MMR |
20220411 |
|
| notation |
C060347 |
|
| PA |
D000970 |
|
| prefLabel |
lanreotide |
|
| RR |
127984-74-1 (lanreotide acetate) IEU56G3J9C 118992-92-0 (lanreotide) |
|
| SC |
1 |
|
| Scope Statement |
somatostatin analogue that suppresses GH/IGF-I hypersecretion in acromegaly patients and used to manage neuroendocrine tumours; do not confuse with BIM 23014 C |
|
| SRC |
Prostaglandins 1989;37(3):345 |
|
| TERMUI |
T197735 T545932 T195478 T195475 T585347 T674789 T197734 T187432 T195477 T274584 T195480 T195479 T195476 T197732 T274583 T274582 T197731 T747340 T187434 T585348 T197733 T187433 T187429 T187430 T187431 |
|
| TH |
NLM (2004) NLM (2009) FDA SRS (2017) ES INN (19XX) NLM (2006) NLM (1989) NLM (1988) |
|
| tui |
T109 T116 T123 T121 |